DBV Technologies (DBVT) Non-Current Debt (2015 - 2020)
DBV Technologies (DBVT) posted quarterly Non-Current Debt of $831844.6 for Q2 2020, down 27.12% year-on-year from $1.1 million in Q3 2019, and up 1.39% on a QoQ basis from $820465.0 in Q4 2019.
DBV Technologies (DBVT) Non-Current Debt (2015 - 2020) Analysis & Trends
DBV Technologies (DBVT) has reported Non-Current Debt for 6 consecutive years, with $831844.6 the latest figure, recorded in Q2 2020.
- Quarterly Non-Current Debt fell 27.12% year-over-year to $831844.6 in Q2 2020, while the trailing twelve-month figure through Jun 2020 was $831844.6 (down 27.12% YoY) and the FY2019 annual result came in at $820465.0, down 43.58% from the prior year.
- Non-Current Debt improved to $831844.6 in Q2 2020 per DBVT's latest filing, from $820465.0 in the prior quarter.
- Over the last five years, Non-Current Debt for DBVT reached as high as $5.8 million in Q4 2016 and fell as low as $820465.0 in Q4 2019.
- A 5-year average of $2.1 million and a median of $1.3 million in 2019 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2016 — Non-Current Debt retreated 13.72% — and 2017, when it tumbled 54.93%.
- Year by year, Non-Current Debt stood at $5.8 million in 2016, then slumped by 54.93% to $2.6 million in 2017, then tumbled by 44.78% to $1.5 million in 2018, then plunged by 43.58% to $820465.0 in 2019, then gained by 1.39% to $831844.6 in 2020.
- According to Business Quant data, Non-Current Debt over the past three periods registered $831844.6, $820465.0, and $1.1 million for Q2 2020, Q4 2019, and Q2 2019 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 831,844.57 |
| Dec 31, 2019 | 820,465.03 |
| Jun 30, 2019 | 1.14 Mn |
| Dec 31, 2018 | 1.45 Mn |
| Dec 31, 2017 | 2.63 Mn |
| Dec 31, 2016 | 5.84 Mn |
| Dec 31, 2015 | 6.77 Mn |